[A retrospective study of oral adverse events with colorectal cancer chemotherapy using bevacizumab].

Purpose: We encountered serious oral mucositis in some patients undergoing colorectal chemotherapy with bevacizumab. We retrospectively investigated the role bevacizumab plays in the occurrence of oral mucositis.

Subjects And Methods: Between January 2008 and December 2009, we encountered 11 patients for whom chemotherapy with bevacizumab had resulted in oral mucositis.